These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

857 related items for PubMed ID: 29869756

  • 1. Molecular mechanisms underlying uremic toxin-related systemic disorders in chronic kidney disease: focused on β2-microglobulin-related amyloidosis and indoxyl sulfate-induced atherosclerosis-Oshima Award Address 2016.
    Yamamoto S.
    Clin Exp Nephrol; 2019 Feb; 23(2):151-157. PubMed ID: 29869756
    [Abstract] [Full Text] [Related]

  • 2. Indoxyl sulfate and atherosclerotic risk factors in hemodialysis patients.
    Taki K, Tsuruta Y, Niwa T.
    Am J Nephrol; 2007 Feb; 27(1):30-5. PubMed ID: 17215572
    [Abstract] [Full Text] [Related]

  • 3. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.
    Madero M, Cano KB, Campos I, Tao X, Maheshwari V, Brown J, Cornejo B, Handelman G, Thijssen S, Kotanko P.
    Clin J Am Soc Nephrol; 2019 Mar 07; 14(3):394-402. PubMed ID: 30755453
    [Abstract] [Full Text] [Related]

  • 4. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.
    Takkavatakarn K, Wuttiputinun T, Phannajit J, Praditpornsilpa K, Eiam-Ong S, Susantitaphong P.
    J Nephrol; 2021 Dec 07; 34(6):1805-1817. PubMed ID: 33484425
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. β(2)-microglobulin amyloidosis.
    Corlin DB, Heegaard NH.
    Subcell Biochem; 2012 Dec 07; 65():517-40. PubMed ID: 23225015
    [Abstract] [Full Text] [Related]

  • 11. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
    Ito S, Yoshida M.
    Toxins (Basel); 2014 Feb 20; 6(2):665-78. PubMed ID: 24561478
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Uremic Toxicity and Bone in CKD.
    Yamamoto S, Fukagawa M.
    J Nephrol; 2017 Oct 20; 30(5):623-627. PubMed ID: 28573386
    [Abstract] [Full Text] [Related]

  • 17. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW, Pawlak K, Karbowska M, Myśliwiec M, Pawlak D.
    BMC Nephrol; 2017 Jan 25; 18(1):35. PubMed ID: 28122514
    [Abstract] [Full Text] [Related]

  • 18. Recent progress in understanding dialysis-related amyloidosis.
    Yamamoto S, Kazama JJ, Narita I, Naiki H, Gejyo F.
    Bone; 2009 Jul 25; 45 Suppl 1():S39-42. PubMed ID: 19303954
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Uremic toxicity and sclerostin in chronic kidney disease patients.
    Desjardins L, Liabeuf S, Oliveira RB, Louvet L, Kamel S, Lemke HD, Vanholder R, Choukroun G, Massy ZA, European Uremic Toxin (EUTox) Work Group.
    Nephrol Ther; 2014 Nov 25; 10(6):463-70. PubMed ID: 25070604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.